TUSC3 and neoplasm: Statistical analysis indicated significant associations between TUSC3 downregulation and clinicopathological characteristics of patients with CSCC, including FIGO stage (p < 0.001), type of tumour growth (p = 0.002), tumour size (p = 0.002), differentiation grade (p < 0.001), stromal invasion (p = 0.024) and pelvic lymph node metastasis (p = 0.004).